Drugs / "Ready to inject" Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product
"Ready to inject" Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05751564 | Apr 2023 → Dec 2024 | osteoarthritis, knee | Universidad de los Andes, Chile | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | "Ready to inject" Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05751564 ↗ |
| Modality | Cell therapy | “Cell therapy” NCT05751564 ↗ |
| Route | Other | “intra-articular therapy” NCT05751564 ↗ |